Project Details
Description
Phase I Study of Nivolumab in Combination with Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma: BTCRC-HEM15-027
| Status | Active |
|---|---|
| Effective start/end date | 5/1/17 → 5/30/24 |
Funding
- BIG TEN CANCER RESEARCH CONSORTIUM
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.